Neuroleptics block high- but not low-dose heroin place preferences: further evidence for a two-system model of motivation
- PMID: 7893405
- DOI: 10.1037//0735-7044.108.6.1128
Neuroleptics block high- but not low-dose heroin place preferences: further evidence for a two-system model of motivation
Abstract
The researchers studied whether 2 separate motivational systems in the brain underlie the rewarding effects of morphine. The brainstem tegmental pedunculopontine nucleus (TPP) is involved in mediating the motivational effects of opiates in nondeprived (drug-naive) rats, whereas dopamine transmission is necessary in mediating the motivational effects of opiates in deprived rats (opiate withdrawal). The results show that heroin's motivational properties obey the same boundary between a nondeprived and a deprived motivational state. Bilateral ibotenic acid lesions of the TPP blocked the acquisition of a place preference for an environment paired with 0.05 mg/kg heroin (a dose that induces no withdrawal aversion) but had no effect on place preference for an environment paired with 0.5 mg/kg heroin (a dose that does induce withdrawal aversion). Dopamine antagonist pretreatment produced the opposite pattern of results.
Similar articles
-
Chronic exposure to morphine does not alter the neural tissues subserving its acute rewarding properties: apparent tolerance is overshadowing.Behav Neurosci. 1992 Apr;106(2):364-73. doi: 10.1037//0735-7044.106.2.364. Behav Neurosci. 1992. PMID: 1317188
-
The parabrachial nucleus: a brain stem substrate critical for mediating the aversive motivational effects of morphine.Behav Neurosci. 1993 Feb;107(1):147-60. doi: 10.1037//0735-7044.107.1.147. Behav Neurosci. 1993. PMID: 8383500
-
Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes.Behav Brain Res. 2002 Feb 1;129(1-2):17-29. doi: 10.1016/s0166-4328(01)00327-8. Behav Brain Res. 2002. PMID: 11809491
-
Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors.Hum Vaccin. 2009 Apr;5(4):214-29. doi: 10.4161/hv.5.4.7556. Epub 2009 Apr 8. Hum Vaccin. 2009. PMID: 19242094 Review.
-
The role of dopamine in drug abuse viewed from the perspective of its role in motivation.Drug Alcohol Depend. 1995 May;38(2):95-137. doi: 10.1016/0376-8716(95)01118-i. Drug Alcohol Depend. 1995. PMID: 7671769 Review.
Cited by
-
Opiate Exposure State Controls a D2-CaMKIIα-Dependent Memory Switch in the Amygdala-Prefrontal Cortical Circuit.Neuropsychopharmacology. 2016 Feb;41(3):847-57. doi: 10.1038/npp.2015.211. Epub 2015 Jul 15. Neuropsychopharmacology. 2016. PMID: 26174594 Free PMC article.
-
Blockade of muscarinic acetylcholine receptors in the ventral tegmental area prevents acquisition of food-rewarded operant responding in rats.Psychopharmacology (Berl). 2006 May;186(1):113-21. doi: 10.1007/s00213-006-0352-0. Epub 2006 Mar 9. Psychopharmacology (Berl). 2006. PMID: 16525855
-
Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area.J Neurosci. 1997 Jan 1;17(1):383-90. doi: 10.1523/JNEUROSCI.17-01-00383.1997. J Neurosci. 1997. PMID: 8987763 Free PMC article.
-
Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.Neurosci Biobehav Rev. 2017 Dec;83:72-82. doi: 10.1016/j.neubiorev.2017.09.022. Epub 2017 Sep 23. Neurosci Biobehav Rev. 2017. PMID: 28951251 Free PMC article. Review.
-
Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement.J Neurosci. 1998 Jul 1;18(13):5035-44. doi: 10.1523/JNEUROSCI.18-13-05035.1998. J Neurosci. 1998. PMID: 9634569 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
